Long-acting antiretrovirals for HIV treatment and PrEP

At the IAS 2017 conference, we got good news about the safety & efficacy of a long-acting antiretroviral injection and a drug in a new class of medications.

Source: Long-acting antiretrovirals for HIV treatment and PrEP

This entry was posted in Uncategorized. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s